LabCompass

Xiaoping Wan

Medicine · The Ohio State University

Established · publishing since 1993

Publications

258

Citations

6,728

Est. group size

~1

Recurring co-author estimate

Active years

34

Publishing since 1993

Research summary
AI-generated

Xiaoping Wan's work centers on the molecular biology of endometrial cancer, particularly how a protein called NSD1 chemically modifies (methylates) another protein, PPARγ, to regulate PTEN activity and control tumor cell metabolism (glycolysis) and cancer progression. The recent record consists largely of supplementary materials tied to a single detailed study on this gene-regulation pathway in endometrial cancer. Broader listed interests span epigenetics, cancer metabolism, and cellular signaling, though the available publication data is dominated by one project.​

Endometrial cancer biologyEpigenetics and DNA/protein methylationCancer metabolism and glycolysisTumor suppressor gene regulation (PTEN, PPARγ)Molecular oncology

Publication counts have fluctuated over the past decade with a notable spike in 2020 and again in 2026, suggesting bursty rather than steadily increasing output, likely tied to large multi-part publications.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 13.6/year recently
2017: 13 publications172018: 11 publications182019: 7 publications192020: 27 publications202021: 10 publications212022: 9 publications222023: 13 publications232024: 7 publications242025: 4 publications252026: 35 publications3526
Recent publications
Publishes in
  • Figshare×4
  • Nature Communications×3
  • eLife×3
  • Oncogene×3
  • Oncotarget×3
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile